All quotes are delayed by at least 15 minutes.
NovaBay Pharmaceuticals, Inc. Membership 
Latest Headlines from Around the Web
Loading
MarketGrader Top Down Analysis
Sector Analysis - NBY ranks 428 out of 579 stocks in the sector
Industry Analysis - NBY ranks 111 out of 176 stocks in the industry
Sentiment Analysis 
Sign up for complete Sentiment Analysis
Fundamental Analysis 
Sign up for complete Fundamental Analysis
| NovaBay Pharmaceuticals, Inc. | Key Financials | Relative to Peer Avg |
|---|---|---|
| Quarterly Revenue Growth | -9.43% | |
| Annual Revenue Growth | -55.71% | |
| Quarterly Net Income Growth | -35.23% | |
| Annual Net Income Growth | -360.55% | |
| Quarterly Free Cash Flow Growth | ||
| Total Debt Relative to Total Capital | N/A | |
| Operating Margin | -255.21% |  Below |
| Return on Equity | -50.018% |
| NovaBay Pharmaceuticals, Inc. (NBY) Dilution Analysis | |||
|---|---|---|---|
| Latest EPS | -$0.07 | EPS Gain From Dilution | $0.02 |
Top Competitors
| Company | Revenue* | Net Income* | Rating | Sentiment |
|---|---|---|---|---|
| AMGN | 4,242.00 | 1,434.00 | Sign up to view | |
| GILD | 2,531.17 | 722.19 | Sign up to view | |
| CELG | 1,471.00 | 384.90 | Sign up to view | |
| BIIB | 1,414.00 | 426.75 | Sign up to view | |
| LIFE | 962.51 | 121.20 | Sign up to view | |
| REGN | 439.66 | 98.87 | Sign up to view | |
| ALXN | 333.79 | 82.22 | Sign up to view | |
| ILMN | 330.96 | -22.59 | Sign up to view | |
| VRTX | 328.37 | -308.02 | Sign up to view | |
| CRL | 291.24 | 25.58 | Sign up to view | |
- Community
